Editor in Chief Dr KK Aggarwal, Padma Shri Awardee Dated:18th August,2019
159 free tests on India’s first diagnostics list
The Indian Council of Medical Research (ICMR) has finalized the country’s first National Essential Diagnostics List (NEDL) that recommends that at least 159 tests should be made available for patients in even rudimentary government health facilities. The list is on the lines of the essential drugs list, the National List of Essential Medicines (NLEM) which was first released in 1996 and last updated in 2015.
The diagnostics list mentions105 general laboratory testsfor a broad range of common conditions,30 disease-specific tests such as for HIV, hepatitis, tuberculosis, and 24 imaging testsincluding X-rays, CT and MRI scans and ultrasound sonography.
“India is the first country to compile such a list that should provide guidance to the government for deciding the kind of diagnostic tests that different healthcare facilities in villages and remote areas require. The list is meant for facilities from village till the district level,” says Dr Kamini Walia, senior scientist, ICMR. Walia led the team from ICMR that compiled the list. The experts from ICMR, health ministry and other organizations started work on compiling the list in March last year. In the absence of lab infrastructure or resources and to minimize the patient movement between providers, ICMR has suggested the so-called “hub and spoke” model for certain tests in the NEDL… (Hindustan Times)
Mera Bharat Mahan 2
Hypoglycemia, starvation and Chandogya Upanishad
As per Chandogya Upanishad, liquid in the food makes urine, blood and Prana; solid food makes stool, muscles and manas; fatty foods make bone, bone marrow and karmendriyas (elimination, procreation, movement, grasping and speech).
Manas in Upanishad means Jnanindriyas (smell, taste, seeing, touch and hearing) along with mind, intellect, ego and chitta or pure intelligence (Fourfold mind or antahkarana chatushtaya). ....read more
Accurate perfusion assessment is very important in patients with critical limb ischemia
The American Heart Association (AHA) has published a new scientific statement on critical limb ischemia. Published online August 12 in the journal Circulation, the statement emphasizes upon the importance of early diagnosis and treatment of critical limb ischemia.
Critical limb ischemia is the most severe form of peripheral artery disease (PAD), which can lead to gangrene and amputations if blood flow is not returned to the limbs.
In the statement,critical limb ischemia has been defined asthe presence of ischemic rest pain, nonhealing wound/ulcer, or gangrene for >2 weeks with associated evidence of hypoperfusion as measured by ankle-brachial index (ABI), ankle pressure, toe-brachial index (TBI), toe systolic pressure, transcutaneous oximetry (TcPo2 ), or skin perfusion pressure (SPP).” ....read more
Do we get a human birth every time we will die?
As per Vedic sciences, Hindu philosophy believes in rebirth unless your Sanchit and Prarabdha Karmas are totally exhausted.
It also believes in liberation in which once your past karma’s debt is over, you do not take a rebirth.
Garuda Purana, on the other hand, says that you can take a birth in animal species which means you can be born like a donkey or a dog. Vedic science, on the other hand, says that once you get a human body, you will either be liberated or get another human body only.....read more
Healthcare News Monitor
Chennai: The Madras High Court has directed the Union Ministry of Health and Family Welfare to approve a draft notification forwarded by the Medical Council of India (MCI) for increasing the upper age limit for Senior Residents/Assistant Professors in government as well as private medical colleges from 40 to 45 years and publish it in the gazette within three weeks. Justices S. Manikumar and Subramonium Prasad also directed the State Health Secretary to give effect to the change after the issuance of the gazette notification. The orders were passed while disposing of a joint writ petition filed last year by six government doctors affected due to fixation of the upper age limit at 40 years with effect from June 8, 2017.
Only qualified pathologists can sign lab reports: HC
The Hindu-Jyoti Shelar
The Bombay High Court has upheld that laboratory reports can be countersigned only by a medical practitioner with a postgraduate qualification in pathology. The court disposed of a public interest litigation (PIL) on the issue, relying on an earlier decision by the Supreme Court and Gujarat High Court while upholding the order last week. The pathologists have hailed the court’s decision and are hopeful that the Maharashtra government starts implementing it. “We have been fighting for this issue for a long time. The government has always sidelined the earlier orders but we hope it will stand by the Bombay High Court’s decision,” said Dr. Prasad Kulkarni from the Maharashtra Association of Practicing Pathologists and Microbiologists (MAPPM). Pathologists have been against people with diplomas in Medical Laboratory Technology signing laboratory reports. According to Dr. Kulkarni, there are nearly 11,000 laboratories in the State, of which nearly 70% are run by technicians.
Pharmabiz India – Neethi Manoharan
The Pharmacy Council of India (PCI) has asked all pharmacy and healthcare institutions across the country to report adverse drug reactions (ADRs) to the existing 270 ADR Monitoring Centres (AMCs) as part of Pharmacovigilance Programme of India (PvPI). In a circular issued on August 9, the PCI had asked all pharmacy institutions, hospital pharmacists and community pharmacists to report the ADRs to strengthen the PvPI in India. As per the PCI notice, all healthcare professionals (clinicians, dentists, pharmacists, nurses etc) are eligible to report ADRs. Duly filled suspected ADR reporting forms can be sent to the nearest AMC or directly to the Indian Pharmacopoeia Commission (IPC) which is the National Coordination Centre (NCC) for PvPI. The submitted information provided in the PCI format is dealt with confidentially. The causality assessment of the ADR is carried out at AMCs by using WHO-Uppasala Monitoring Centre (UMC) scale. The analysed form is then forwarded to the NCC through ADR database. Mandatory fields for suspected ADR reporting form are patient initials, age at the onset of ADR, reaction terms, date of onset of ADR, medication details and reporter information. Earlier on August 6, the IPC had also directed all the Principals of the Pharm D institutions in the country to report ADRs from their institutions. “It is a known fact that as a Part of Pharm D. curriculum, students collect ADRs from hospitals as their project work. The practice of collecting ADR information from hospitals can play a crucial role in contributing to patient safety and to understand the benefit and risk of medicines.
NPPA issues notification to extend ceiling price on knee implants by one year; puts cap of 10% annual increase in prices
Pharmabiz India – Shardul Nautiyal
The national drug pricing regulator, National Pharmaceutical Pricing Authority (NPPA) has notified that ceiling price of orthopaedic knee implants should not be increased beyond 10 per cent in a given year. Orthopaedic knee implants were brought under price control two years ago to make it affordable to the common man. As per the data analysis of NPPA, price control was required as there was huge margin in trade of orthopaedic knee implants which led to unreasonable and unethical profiteering. “This is in continuation to the notifications issued by NPPA dated August 16, 2017 and dated August 13, 2018 regarding fixation of ceiling price of orthopaedic knee implants issued under Para 19 of the Drug Price Control Order (DPCO-2013),” as per the NPPA notification issued recently. NPPA in its recent meeting reviewed the matter of price monitoring of knee implants and found that knee implants have become affordable because of price capping exercise as per DPCO-2013. As per the data submitted by manufacturers and importers there has been an increase of 30 per cent in the sales of knee implants during July, 2018 to June, 2019 due to price control. As per the notification, NPPA stated that ceiling price of orthopaedic knee implants will be monitored as per the provisions of Paragraph 20(1) of the DPCO- 2013. This will be applicable for a period of one year from August 16, 2019 till August 15, 2020 unless revised by another notification.